Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors

被引:46
作者
Justo, D
Prokhorov, V
Heller, K
Zeltser, D
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Internal Med D, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Emergency Med, Tel Aviv, Israel
关键词
antidepressant; antipsychotic; QT interval; torsade de pointes;
D O I
10.1111/j.1600-0447.2004.00469.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To investigate all published case reports of torsade de pointes (TdP) induced by psychotropic drugs (PDs) in order to examine the prevalence of risk factors for TdP prior to the drug initiation. Method: We found 45 reports on 70 patients with TdP induced by PDs. Each report was analyzed for the presence of risk factors for TdP: female gender, heart disease, hypokalemia, high doses of offending agent, concomitant use of a QT interval prolonging agent, and a history of long-QT syndrome. Results: Female gender was the most common risk factor for TdP (71.4%). The other studied risk factors were also frequently present (34.2-14.2%). Nearly all patients had at least one and 51 (73%) patients had >2 risk factors for TdP prior to PD initiation. Conclusion: We wish to raise the level of awareness of risk factors for TdP in the psychiatric community.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 85 条
[1]   IN-VITRO ELECTROPHYSIOLOGICAL DETECTION OF IATROGENIC ARRHYTHMOGENICITY [J].
ADAMANTIDIS, MM ;
KERRAM, P ;
DUPUIS, BA .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (05) :391-407
[2]   QT PROLONGATION AND TORSADE-DE-POINTES VENTRICULAR-TACHYCARDIA PRODUCED BY KETANSERIN [J].
ALDARIZ, AE ;
ROMERO, H ;
BARONI, M ;
BAGLIVO, H ;
ESPER, RJ .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (06) :836-841
[3]   Doxepin-induced torsade de pointes tachycardia [J].
Alter, P ;
Tontsch, D ;
Grimm, W .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (05) :384-385
[4]   FLUOXETINE AND VENTRICULAR TORSADE - IS THERE A LINK [J].
APPLEBY, M ;
MBEWU, A ;
CLARKE, B .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 49 (02) :178-180
[5]   Greater quinidine-induced QTc interval prolongation in women [J].
Benton, RE ;
Sale, M ;
Flockhart, DA ;
Woosley, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (04) :413-418
[6]   KETANSERIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN HYPERTENSION AND PERIPHERAL VASCULAR-DISEASE [J].
BROGDEN, RN ;
SORKIN, EM .
DRUGS, 1990, 40 (06) :903-949
[7]  
CASAZZA F, 1986, Giornale Italiano di Cardiologia, V16, P1058
[8]  
COINTE R, 1989, ARCH MAL COEUR VAISS, V82, P401
[10]   Thioridazine, diarrhoea and torsades de pointe [J].
Denvir, MA ;
Sood, A ;
Dow, R ;
Brady, AJ ;
Rankin, AC .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1998, 91 (03) :145-147